CellmaEHR: Leading Oncology Clinical Management Software for Cancer Care
Table of Contents Help Others Discover – Click to Share! Facebook Twitter LinkedIn Your browser does not support the audio tag. Table of Contents Cancer prevalence has risen from nearly 3 million in 2020 to almost 3.5 million in 2025 and is expected to keep increasing. The demand for cancer care in the UK is at an unprecedented level. In 2025, there will be over 400,000 new cases for cancer, or roughly 1,100 people diagnosed per day. About 45.5% diagnosed in England (for those with known stage) are found at Stage 3 or 4. Breast, prostate, lung, and bowel cancers together account for over 50% of all new cancer cases. The NHS Long Term Plan aims to reach 75% of cancers diagnosed at early stage (1 or 2) by 2028. While survival rates do continue to rise, the sheer volume of cancer incidence and complexity of care pathways has markedly increased work engagement for oncology teams. From referrals, diagnostics, treatment planning, multidisciplinary meetings and survivorship care, administrative work demands have absorbed precious time that could be used more productively with patient care. This is where CellmaEHR steps in. Designed to reduce the oncology department administrative burden while aligning with all NHS integrations and standards. CellmaEHR, an oncology clinical management software aligns with NHS integrations, datasets, and the objectives of the NHS 10 Year Plan. Cellma reduces administrative burden while enabling better care coordination, neighbourhood-based support for early detection, and integration with modern models of care such as virtual wards. NHS Standards and Integrations Supported by Cellma Cellma adheres with and integrates fully with the complete suite of NHS datasets and guidelines for oncology-related data compliance and continuity of cancer pathways: Activity Datasets: Cancer Waiting Times (CWT), Hospital Episode Statistics (HES), Systemic Anti-Cancer Therapy (SACT), Radiotherapy Dataset (RTDS). Outcome Datasets: National Cancer Registration and Analysis Service (NCRAS), Office for National Statistics (ONS), National Cancer Audits, and Cancer Patient Experience Survey (CPES). Standards & Compliance: Fully compatible with NHS Spine services, GP systems, NHS App, Neighbourhood Care Records, and Virtual Ward Integration, while supporting HL7, FHIR, and CQC requirements for interoperability and data governance. Interoperability & Technical Standards: Cellma is HL7 v2/v3 message, FHIR APIs, DICOM for imaging, SNOMED CT terminology, ICD-10/11 coding, Read Codes and OPCS-4 procedure codes enabled, facilitating the consistent transfer and reporting of data across the complete oncology care pathway. By using these data sets, Cellma reduces duplication, allows for reporting to be automated, and allows oncology departments to demonstrate they are meeting national standards for performance with no additional administrative burden on the oncology department. Clinical Scope: The Management of Oncology Conditions with Cellma Oncology is not a condition, but a spectrum of cancers and associated issues. The most common cancers in the UK – breast, lung, prostate, and bowel, account for over half of all cases. Beyond these, oncology care must manage rare cancers, paediatric cancers, haematological malignancies, and acute oncology presentations such as neutropenic sepsis or spinal cord compression. Cellma facilitates the complete clinical process: Referral and Diagnosis: Oversees urgent GP referrals in the 2-week wait process, interacts with imaging and pathology systems, and helps automate the sharing of results. Multidisciplinary Team (MDT) Management: Provides structured MDT templates in which oncologists, radiologists, and surgeons can collaboratively document decisions in real time. Treatment Planning and Monitoring: Supports systemic anti-cancer therapy (chemotherapy, targeted therapy, immunotherapy), radiotherapy and surgical oncology. Acute Oncology Services: Records emergency admissions, and treatment complications, and ensures an expedient escalation. Follow-up & Survivorship: Generates automated end-of-treatment summaries, follow-up schedules, and survivorship care plans. Cellma digitises and coordinates these stages in a manner that maintains absolute clinical meaningfulness and reduces the complexity of the Oncology department’s administration associated with paper records, typing the same information in multiple systems, and broken communication. Key Features of Cellma EHR for Oncology Care Oncology departments face a unique set of administrative burdens: high referral volumes, complex treatment regimens, constant reporting to national datasets, and the coordination of MDTs. Cellma offers a solution to these issues in a clinically rich fully integrated platform: Electronic Patient Record (EPR): Gathers all oncology data (referrals, test results, imaging, treatment summaries) into a single locus of easily accessible information. This prevents redundancy and enables continuity of care across various providers. Patient Admission and Scheduling (PAS): Automates scheduling for diagnostics, consultations, and treatments, reducing appointment backlogs and cutting waiting times. Document Management: Digitises consent forms, MDT outcomes, and treatment plans, ensuring fast retrieval and compliance with NHS audits. Laboratory and Imaging Integrations: Integrates with pathology, radiology, and genomic testing platforms which are essential for accurate staging of cancer and personalised therapy. Pharmacy and Chemotherapy Management: Monitors all aspects of systemic anti-cancer therapy prescriptions for each patient, the dosage adjustment and side-effect management allowing minimising all medication errors and administration workload burden from therapy management. Theatre Management: Manages all aspects of surgical oncology scheduling and consumables so that cancer surgery is not delayed. Business Intelligence and Reporting: Provides automated CWT, SACT submissions, RTDS submissions, and NCRAS submissions all of which are useful to expedite manual reporting which causes delays in the Oncology Department Administration. Each module is designed to alleviate a particular pain point – whether it is delays in referral, data that has been missed by the MDT, or whether it is just the manual workload through reporting. With Cellma oncology teams spend less time on admin and more time on the patient-centred care. Security and Compliance in Oncology Care Oncology data is amongst some of the most sensitive patient health data in healthcare. To create confidentiality and trust for patients Cellma uses: Controls using role-based access and authorisation, preventing unauthorised access. End-to-end encryption of all data, in transit and at rest. Compliance with GDPR, NHS Digital standards and ISO certifications. Audit trails to provide accountability and transparency of all clinical and administrative actions. By implementing these, Cellma protects oncology data while reducing the risk of exposure to compliance breaches which only serve to increase the oncology department administrative burden. Oncology teams across the UK are facing high demand, increased complexity, and additional administrative requirements. Cellma EHR is a clinically robust
